Biotechnology Investment Incentive Tax Credit (BIITC)

The Biotechnology Investment Incentive Tax Credit, or BIITC, sits under the Maryland Department of Commerce and helps early-stage biotechnology companies attract private capital. The state does not hand the credit to the company itself; instead, it gives an income tax credit to qualifying investors who back a Qualified Maryland Biotechnology Company, or QMBC. The program is built for Maryland-based biotech firms that need outside investment to keep growing. The credit ranges from 33 percent to 75 percent of the eligible investment, with maximum credits of $250,000 to $750,000 depending on location and opportunity-zone status. To qualify, the company must be headquartered in Maryland, have fewer than 50 employees, and have been in active business for no more than 12 years. Investors start with QMBC certification by March 31, then file their application by April 30, after queue registration opens in September. This route is strongest for founders who can show a credible commercialization path and for investors who want a state incentive tied to an early biotech bet. The process rewards clean corporate records, timely filings, and a company profile that clearly fits the state definition of a biotech business. It is less useful as direct operating capital than as leverage for a financing round.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.